995
Views
0
CrossRef citations to date
0
Altmetric
Review

Unleashing light's healing power: an overview of photobiomodulation for Alzheimer's treatment

, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Article: FSO922 | Received 09 Aug 2023, Accepted 17 Oct 2023, Published online: 24 May 2024

References

  • Cardoso F dos S, Lopes Martins RÁB, Gomes da Silva S. Therapeutic Potential of Photobiomodulation In Alzheimer's Disease: A Systematic Review. J Lasers Med Sci. 11(Suppl. 1), S16–S22 (2020).
  • Suresh S, Begum RF, Singh SA, V C. Anthocyanin as a therapeutic in Alzheimer's disease: a systematic review of preclinical evidences. Ageing Res Rev. 76, 101595 (2022).
  • Shen Q, Liu L, Gu X, Xing D. Photobiomodulation suppresses JNK3 by activation of ERK/MKP7 to attenuate AMPA receptor endocytosis in Alzheimer's disease. Aging Cell. 20(1), e13289 (2021).
  • Tao L, Liu Q, Zhang F et al. Microglia modulation with 1070-nm light attenuates Aβ burden and cognitive impairment in Alzheimer's disease mouse model. Light Sci Appl. 10(1), 179 (2021).
  • AS S, Vellapandian C. Structure of the Blood Brain Barrier and its Role in the Transporters for the Movement of Substrates across the Barriers. Curr Drug Metab. 24(4), 250–269 (2023).
  • Chang J, Ren Y, Wang R, Li C, Wang Y, Ping Chu X. Transcranial Low-Level Laser Therapy for Depression and Alzheimer's Disease. Neuropsychiatry 08(02), 477–483 (2018).
  • Chen C, Liang Z, Zhou B et al. In Vivo Near-Infrared Two-Photon Imaging of Amyloid Plaques in Deep Brain of Alzheimer's Disease Mouse Model. ACS Chem Neurosci. 9(12), 3128–3136 (2018).
  • Gutiérrez-Menéndez A, Marcos-Nistal M, Méndez M, Arias JL. Photobiomodulation as a promising new tool in the management of psychological disorders: a systematic review. Neurosci. Biobehav. Rev. 119, 242–254 (2020).
  • Suresh S, Singh SA, Vellapandian C. Bisphenol A exposure links to exacerbation of memory and cognitive impairment: a systematic review of the literature. Neurosci. Biobehav. Rev. 143, 104939 (2022).
  • Hatefi Y. The mitochondrial electron transport and oxidative phosphorylation system. Annu. Rev. Biochem. 54(1), 1015–1069 (1985).
  • Grillo SL, Duggett NA, Ennaceur A, Chazot PL. Non-invasive infra-red therapy (1072 nm) reduces β-amyloid protein levels in the brain of an Alzheimer's disease mouse model, TASTPM. J. Photochem. Photobiol. B. 123, 13–22 (2013).
  • Wang X, Wang W, Li L, Perry G, Lee H, Zhu X. Oxidative stress and mitochondrial dysfunction in Alzheimer's disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1842(8), 1240–1247 (2014).
  • Singh SA, Suresh S, Vellapandian C. Ozone-induced neurotoxicity: in vitro and in vivo evidence. Ageing Res Rev. 91, 102045 (2023).
  • Singh SA, Suresh S, Singh A, Chandran L, Vellapandian C. Perspectives of ozone induced neuropathology and memory decline in Alzheimer's disease: a systematic review of preclinical evidences. Environmental Pollution. 313, 120136 (2022).
  • Cassano P, Petrie SR, Hamblin MR, Henderson TA, Iosifescu DV. Review of transcranial photobiomodulation for major depressive disorder: targeting brain metabolism, inflammation, oxidative stress, and neurogenesis. Neurophotonics. 3(3), 031404 (2016).
  • Oron U, Ilic S, De Taboada L, Streeter J. Ga-As (808 nm) Laser Irradiation Enhances ATP Production in Human Neuronal Cells in Culture. Photomed Laser Surg. 25(3), 180–182 (2007).
  • Yang L, Youngblood H, Wu C, Zhang Q. Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation. Transl Neurodegener. 9(1), 19 (2020).
  • Hamblin M. Photobiomodulation for Alzheimer's Disease: Has the Light Dawned? Photonics. 6(3), 77 (2019).
  • Hamblin MR. Shining light on the head: photobiomodulation for brain disorders. BBA Clin. 6, 113–124 (2016).
  • Glass GE. Photobiomodulation: The Clinical Applications of Low-Level Light Therapy. Aesthet Surg J. 41(6), 723–738 (2021).
  • Davalos D, Grutzendler J, Yang G et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci. 8(6), 752–758 (2005).
  • Lane N. Power games. Nature 443(7114), 901–903 (2006).
  • Manczak M, Calkins MJ, Reddy PH. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage. Hum. Mol. Genet. 20(13), 2495–2509 (2011).
  • Lim W, Kim J, Kim S et al. Modulation of Lipopolysaccharide-Induced NF-κB Signaling Pathway by 635 nm Irradiation via Heat Shock Protein 27 in Human Gingival Fibroblast Cells. Photochem Photobiol. 89(1), 199–207 (2013).
  • Hanna R, Dalvi S, Bensadoun RJ, Benedicenti S. Role of Photobiomodulation Therapy in Modulating Oxidative Stress in Temporomandibular Disorders. A Systematic Review and Meta-Analysis of Human Randomised Controlled Trials. Antioxidants. 10(7), 1028 (2021).
  • Bartos A, Grondin Y, Bortoni ME et al. Pre-conditioning with near infrared photobiomodulation reduces inflammatory cytokines and markers of oxidative stress in cochlear hair cells. J Biophotonics. 9(11–12), 1125–1135 (2016).
  • Amaroli A, Pasquale C, Zekiy A et al. Photobiomodulation and Oxidative Stress: 980 nm Diode Laser Light Regulates Mitochondrial Activity and Reactive Oxygen Species Production. Oxid Med Cell Longev. 2021, 1–11 (2021).
  • Stepanov YV, Golovynska I, Zhang R et al. Near-infrared light reduces β-amyloid-stimulated microglial toxicity and enhances survival of neurons: mechanisms of light therapy for Alzheimer's disease. Alzheimers Res Ther. 14(1), 84 (2022).
  • Golovynska I, Golovynskyi S, Stepanov YV, Stepanova LI, Qu J, Ohulchanskyy TY. Red and near-infrared light evokes Ca2+ influx, endoplasmic reticulum release and membrane depolarization in neurons and cancer cells. J. Photochem. Photobiol. B. 214, 112088 (2021).
  • De Taboada L, Yu J, El-Amouri S et al. Transcranial Laser Therapy Attenuates Amyloid-β Peptide Neuropathology in Amyloid-β Protein Precursor Transgenic Mice. Journal of Alzheimer's Disease. 23(3), 521–535 (2011).
  • Yin Q, Chang H, Shen Q, Xing D. Photobiomodulation therapy promotes the ATP-binding cassette transporter A1-dependent cholesterol efflux in macrophage to ameliorate atherosclerosis. J Cell Mol Med. 25(11), 5238–5249 (2021).
  • Salehpour F, Majdi A, Pazhuhi M et al. Transcranial Photobiomodulation Improves Cognitive Performance in Young Healthy Adults: A Systematic Review and Meta-Analysis. Photobiomodul Photomed Laser Surg. 37(10), 635–643 (2019).
  • Montazeri K, Farhadi M, Fekrazad R, Akbarnejad Z, Chaibakhsh S, Mahmoudian S. Transcranial photobiomodulation in the management of brain disorders. J. Photochem. Photobiol. B. 221, 112207 (2021).
  • Zomorrodi R, Saltmarche AE, Loheswaran G, Ho KF, Lim L. [P2–043]: COMPLEMENTARY EEG EVIDENCE FOR A SIGNIFICANTLY IMPROVED ALZHEIMER's DISEASE CASE AFTER PHOTOBIOMODULATION TREATMENT. Alzheimer's & Dementia. 13(7S_Part_12), P621 (2017).
  • Houmani N, Vialatte F, Gallego-Jutglà E et al. Diagnosis of Alzheimer's disease with Electroencephalography in a differential framework. PLoS One. 13(3), e0193607 (2018).
  • Escudero J, Abásolo D, Hornero R, Espino P, López M. Analysis of electroencephalograms in Alzheimer's disease patients with multiscale entropy. Physiol. Meas. 27(11), 1091–1106 (2006).
  • Grillo SL, Duggett NA, Ennaceur A, Chazot PL. Non-invasive infra-red therapy (1072 nm) reduces β-amyloid protein levels in the brain of an Alzheimer's disease mouse model, TASTPM. J. Photochem. Photobiol. B. 123, 13–22 (2013).
  • Hennessy M, Hamblin MR. Photobiomodulation and the brain: a new paradigm. Journal of Optics. 19(1), 013003 (2017).
  • Lim L. The Growing Evidence for Photobiomodulation as a Promising Treatment for Alzheimer's Disease. J Biosci Med (Irvine). 06(12), 100–110 (2018).
  • Zinchenko E, Klimova M, Mamedova A et al. Photostimulation of Extravasation of Beta-Amyloid through the Model of Blood-Brain Barrier. Electronics (Basel). 9(6), 1056 (2020).
  • de Freitas LF, Hamblin MR. Proposed Mechanisms of Photobiomodulation or Low-Level Light Therapy. IEEE Journal of Selected Topics in Quantum Electronics. 22(3), 348–364 (2016).
  • Zhang Z, Shen Q, Wu X, Zhang D, Xing D. Activation of PKA/SIRT1 signaling pathway by photobiomodulation therapy reduces Aβ levels in Alzheimer's disease models. Aging Cell. 19(1), e13054 (2020).
  • Semyachkina-Glushkovskaya O, Klimova M, Iskra T et al. Transcranial Photobiomodulation of Clearance of Beta-Amyloid from the Mouse Brain: Effects on the Meningeal Lymphatic Drainage and Blood Oxygen Saturation of the Brain. In: Nemoto EM, Harrison EM, Pias SC et al. (Eds.) Oxygen Transport to Tissue XLII. Springer, Cham. 1269, 57–61 (2021).
  • Chan AS, Lee TL, Yeung MK, Hamblin MR. Photobiomodulation improves the frontal cognitive function of older adults. Int. J. Geriatr. Psychiatry 34(2), 369–377 (2019).
  • Baik JS, Lee TY, Kim NG et al. Effects of Photobiomodulation on Changes in Cognitive Function and Regional Cerebral Blood Flow in Patients with Mild Cognitive Impairment: A Pilot Uncontrolled Trial. Journal of Alzheimer's Disease. 83(4), 1513–1519 (2021).
  • Salehpour F, Khademi M, Bragin DE, DiDuro JO. Photobiomodulation Therapy and the Glymphatic System: Promising Applications for Augmenting the Brain Lymphatic Drainage System. Int J Mol Sci. 23(6), (2022).
  • Ashleigh T, Swerdlow RH, Beal MF. The role of mitochondrial dysfunction in Alzheimer's disease pathogenesis. Alzheimer's & Dementia. 19 (1), 333–342 (2022).
  • Hunt RJ, Granat L, McElroy GS, Ranganathan R, Chandel NS, Bateman JM. Mitochondrial stress causes neuronal dysfunction via an ATF4-dependent increase in L-2-hydroxyglutarate. J. Cell Biol. 218(12), (2019).
  • Manczak M, Calkins MJ, Reddy PH. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage. Hum. Mol. Genet. 20(13), 2495–2509 (2011).
  • Gao J, Zhao L, Wang J et al. C-Phycocyanin Ameliorates Mitochondrial Fission and Fusion Dynamics in Ischemic Cardiomyocyte Damage. Front Pharmacol. 10, 10 (2019).
  • Wang X, Su B, Lee H-g et al. Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease. J. Neurosci. 29(28), 9090–9103 (2009).
  • Bhatia S, Rawal R, Sharma P, Singh T, Singh M, Singh V. Mitochondrial Dysfunction in Alzheimer's Disease: Opportunities for Drug Development. Curr Neuropharmacol. 20(4), 675–692 (2022).
  • Yang L, Youngblood H, Wu C, Zhang Q. Mitochondria as a target for neuroprotection: role of methylene blue and photobiomodulation. Transl Neurodegener. 9(1), 19 (2020).
  • Wang W, Zhao F, Ma X, Perry G, Zhu X. Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances. Mol Neurodegener. 15(1), 30 (2020).
  • da Silva Oliveira VR, Cury DP, Yamashita LB et al. Photobiomodulation induces antinociception, recovers structural aspects and regulates mitochondrial homeostasis in peripheral nerve of diabetic mice. J Biophotonics. 11(9), e201800110 (2018).
  • Hatefi Y. The mitochondrial electron transport and oxidative phosphorylation system. Annu. Rev. Biochem. 54(1), 1015–1069 (1985).
  • Dewey C, Brunke M, Sakovitch K. Transcranial photobiomodulation (laser) therapy for cognitive impairment: a review of molecular mechanisms and potential application to canine cognitive dysfunction (CCD). Open Vet J. 12(2), 256 (2022).
  • Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol. 94(2), 199–212 (2018).
  • Sarti P, Giuffré A, Forte E, Mastronicola D, Barone MC, Brunori M. Nitric Oxide and Cytochrome c Oxidase: Mechanisms of Inhibition and NO Degradation. Biochem. Biophys. Res. Commun. 274(1), 183–187 (2000).
  • Yokomizo S, Roessing M, Morita A et al. Near-infrared II photobiomodulation augments nitric oxide bioavailability via phosphorylation of endothelial nitric oxide synthase. The FASEB Journal. 36(9), e22490 (2022).
  • Cardoso F dos S, Barrett DW, Wade Z, Gomes da Silva S, Gonzalez-Lima F. Photobiomodulation of Cytochrome c Oxidase by Chronic Transcranial Laser in Young and Aged Brains. Front Neurosci. 16, 16 (2022).
  • Amaroli A, Pasquale C, Zekiy A et al. Photobiomodulation and Oxidative Stress: 980 nm Diode Laser Light Regulates Mitochondrial Activity and Reactive Oxygen Species Production. Oxid Med Cell Longev. 2021, 1–11 (2021).
  • Golovynska I, Golovynskyi S, Qu J. Comparing the Impact of NIR, Visible and UV Light on ROS Upregulation via Photoacceptors of Mitochondrial Complexes in Normal, Immune and Cancer Cells. Photochem Photobiol. 99(1), 106–119 (2023).
  • Xu Z, Guo X, Yang Y et al. Low-Level Laser Irradiation Improves Depression-Like Behaviors in Mice. Mol. Neurobiol. 54(6), 4551–4559 (2017).
  • Abijo A, Lee C-Y, Huang C-Y, Ho P-C, Tsai K-J. The Beneficial Role of Photobiomodulation in Neurodegenerative Diseases. Biomedicines. 11(7), 1828 (2023).
  • Hamblin MR. Mechanisms and Mitochondrial Redox Signaling in Photobiomodulation. Photochem Photobiol. 94(2), 199–212 (2018).
  • Brochetti RA, Leal MP, Rodrigues R et al. Photobiomodulation therapy improves both inflammatory and fibrotic parameters in experimental model of lung fibrosis in mice. Lasers Med Sci. 32(8), 1825–1834 (2017).
  • Wu S, Su Y, Wang L, Sun B, Jiang X. The effects of photobiomodulation therapy on inflammatory mediators, immune infiltration, and angiogenesis in a mouse model of rosacea. Ann Transl Med. 10(15), 831–831 (2022).
  • d'Errico P, Ziegler-Waldkirch S, Aires V et al. Microglia contribute to the propagation of Aβ into unaffected brain tissue. Nat Neurosci. 25(1), 20–25 (2022).
  • Tao L, Liu Q, Zhang F et al. Microglia modulation with 1070-nm light attenuates Aβ burden and cognitive impairment in Alzheimer's disease mouse model. Light Sci Appl. 10(1), 179 (2021).
  • Yang F, Liu Y, Tu J et al. Activated astrocytes enhance the dopaminergic differentiation of stem cells and promote brain repair through bFGF. Nat Commun. 5(1), 5627 (2014).
  • Yang L, Tucker D, Dong Y et al. Photobiomodulation therapy promotes neurogenesis by improving post-stroke local microenvironment and stimulating neuroprogenitor cells. Exp. Neurol. 299, 86–96 (2018).
  • Yang L, Tucker D, Dong Y et al. Photobiomodulation therapy promotes neurogenesis by improving post-stroke local microenvironment and stimulating neuroprogenitor cells. Exp. Neurol. 299, 86–96 (2018).
  • Guo S, Wang H, Yin Y. Microglia Polarization From M1 to M2 in Neurodegenerative Diseases. Front Aging Neurosci. 14, 14 (2022).
  • Yao M, Zhao Z, Wei L, Zhou D, Xue Z, Ge S. HSF1/HSP pathway in the hippocampus is involved in SIRT1-mediated caloric restriction-induced neuroprotection after surgery in aged mice. Exp. Gerontol. 119, 184–192 (2019).
  • Kazemikhoo N, Ghadimi T, Vaghardoost R et al. Effects of Photobiomodulation and Split-Thickness Skin Grafting in the Prognosis of Wound Healing in Children with Deep Burn Ulcers. Photobiomodul Photomed Laser Surg. 40(2), 148–154 (2022).
  • Farfara D, Tuby H, Trudler D et al. Low-Level Laser Therapy Ameliorates Disease Progression in a Mouse Model of Alzheimer's Disease. J. Mol. Neurosci. 55(2), 430–436 (2015).
  • Neves LMS, Gonçalves ECD, Cavalli J et al. Photobiomodulation Therapy Improves Acute Inflammatory Response in Mice: the Role of Cannabinoid Receptors/ATP-Sensitive K+ Channel/p38-MAPK Signalling Pathway. Mol. Neurobiol. 55(7), 5580–5593 (2018).
  • Macedo DB, Tim CR, Kido HW et al. Influence of photobiomodulation therapy on the treatment of pulmonary inflammatory conditions and its impact on COVID-19. Lasers Med Sci. 37(3), 1921–1929 (2022).
  • Karkada G, Maiya GA, Houreld NN et al. Effect of photobiomodulation therapy on inflammatory cytokines in healing dynamics of diabetic wounds: a systematic review of preclinical studies. Arch. Physiol. Biochem. 129(3), 663–670 (2020).
  • Lim W, Kim J, Kim S et al. Modulation of Lipopolysaccharide-Induced NF-κB Signaling Pathway by 635 nm Irradiation via Heat Shock Protein 27 in Human Gingival Fibroblast Cells. Photochem Photobiol. 89(1), 199–207 (2013).
  • Grillo SL, Duggett NA, Ennaceur A, Chazot PL. Non-invasive infra-red therapy (1072 nm) reduces β-amyloid protein levels in the brain of an Alzheimer's disease mouse model, TASTPM. J. Photochem. Photobiol. B. 123, 13–22 (2013).
  • Rivas-Arancibia S, Guevara-Guzmán R, López-Vidal Y et al. Oxidative Stress Caused by Ozone Exposure Induces Loss of Brain Repair in the Hippocampus of Adult Rats. Toxicological Sciences. 113(1), 187–197 (2010).
  • Stepanov YV, Golovynska I, Zhang R et al. Near-infrared light reduces β-amyloid-stimulated microglial toxicity and enhances survival of neurons: mechanisms of light therapy for Alzheimer's disease. Alzheimers Res Ther. 14(1), 84 (2022).
  • Zhao Y, Zhao B. Oxidative Stress and the Pathogenesis of Alzheimer's Disease. Oxid Med Cell Longev. 2013, 1–10 (2013).
  • Bai R, Guo J, Ye X-Y, Xie Y, Xie T. Oxidative stress: the core pathogenesis and mechanism of Alzheimer's disease. Ageing Res Rev. 77, 101619 (2022).
  • Buendia I, Michalska P, Navarro E, Gameiro I, Egea J, León R. Nrf2–ARE pathway: an emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases. Pharmacol. Ther. 157, 84–104 (2016).
  • Tönnies E, Trushina E. Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease. Journal of Alzheimer's Disease. 57(4), 1105–1121 (2017).
  • Purushothuman S, Johnstone DM, Nandasena C, Mitrofanis J, Stone J. Photobiomodulation with near infrared light mitigates Alzheimer's disease-related pathology in cerebral cortex – evidence from two transgenic mouse models. Alzheimers Res Ther. 6(1), 2 (2014).
  • Enengl J, Hamblin MR, Dungel P. Photobiomodulation for Alzheimer's Disease: Translating Basic Research to Clinical Application. Journal of Alzheimer's Disease. 75(4), 1073–1082 (2020).
  • Heo J-C, Park J-A, Kim D-K, Lee J-H. Photobiomodulation (660 nm) therapy reduces oxidative stress and induces BDNF expression in the hippocampus. Sci Rep. 9(1), 10114 (2019).
  • Maiello M, Losiewicz OM, Bui E et al. Transcranial Photobiomodulation with Near-Infrared Light for Generalized Anxiety Disorder: A Pilot Study. Photobiomodul Photomed Laser Surg. 37(10), 644–650 (2019).
  • Yuan Y, Cassano P, Pias M, Fang Q. Transcranial photobiomodulation with near-infrared light from childhood to elderliness: simulation of dosimetry. Neurophotonics. 7(01), 1 (2020).
  • Wang X, Han Y, Chen F et al. Glutathione Peroxidase 1 Protects Against Peroxynitrite-Induced Spiral Ganglion Neuron Damage Through Attenuating NF-κB Pathway Activation. Front Cell Neurosci. 16, 16 (2022).
  • Hashmi JT, Huang Y, Osmani BZ, Sharma SK, Naeser MA, Hamblin MR. Role of Low-Level Laser Therapy in Neurorehabilitation. PM&R. 2(12S), S292–S305 (2010).
  • Zhang D, Shen Q, Wu X, Xing D. Photobiomodulation Therapy Ameliorates Glutamatergic Dysfunction in Mice with Chronic Unpredictable Mild Stress-Induced Depression. Oxid Med Cell Longev. 2021, 1–20 (2021).
  • Van Someren EJW, Swaab DF, Colenda CC, Cohen W, McCall WV, Rosenquist PB. Bright light therapy: improved sensitivity to its effects on rest-activity rhythms in alzheimer patients by application of nonparametric methods. Chronobiol. Int. 16(4), 505–518 (1999).
  • Rheaume YL, Manning BC, Harper DG, Volicer L. Effect of light therapy upon disturbed behaviors in Alzheimer patients. American Journal of Alzheimer's Disease. 13(6), 291–295 (1998).
  • Ismail R, Hansen AK, Parbo P et al. The Effect of 40-Hz Light Therapy on Amyloid Load in Patients with Prodromal and Clinical Alzheimer's Disease. Int J Alzheimers Dis. 2018, 1–5 (2018).
  • Hamblin MR. Photobiomodulation for traumatic brain injury and stroke. J. Neurosci. Res. 96(4), 731–743 (2018).
  • Hamblin MR. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophys. 4(3), 337–361 (2017).
  • Cardoso FDS, Salehpour F, Coimbra NC, Gonzalez-Lima F, Gomes da Silva S. Photobiomodulation for the treatment of neuroinflammation: a systematic review of controlled laboratory animal studies. Front Neurosci. 16, 1006031 (2022).
  • Hennessy M, Hamblin MR. Photobiomodulation and the brain: a new paradigm. J Opt. 19(1), 013003 (2017).
  • Hong N. Photobiomodulation as a treatment for neurodegenerative disorders: current and future trends. Biomed Eng Lett. 9(3), 359–366 (2019).
  • Hamblin MR. Photobiomodulation for traumatic brain injury and stroke. J. Neurosci. Res. 96(4), 731–743 (2018).
  • Van Bulck M, Sierra-Magro A, Alarcon-Gil J, Perez-Castillo A, Morales-Garcia JA. Novel Approaches for the Treatment of Alzheimer's and Parkinson's Disease. Int J Mol Sci. 20(3), 719 (2019).
  • Houreld N. Healing Effects of Photobiomodulation on Diabetic Wounds. Applied Sciences. 9(23), 5114 (2019).
  • Cotler HB, Chow RT, Hamblin MR, Carroll J. The Use of Low Level Laser Therapy (LLLT) For Musculoskeletal Pain. MOJ Orthop Rheumatol. 2(5), 00068 (2015).
  • Hosseinpour S, Tunér J, Fekrazad R. Photobiomodulation in Oral Surgery: A Review. Photobiomodul Photomed Laser Surg. 37(12), 814–825 (2019).
  • Avci P, Gupta A, Sadasivam M et al. Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring. Semin. Cutan. Med. Surg. 32(1), 41–52 (2013).
  • Lin JB, Murakami Y, Miller JW, Vavvas DG. Neuroprotection for Age-Related Macular Degeneration. Ophthalmol. Sci. 2(4), 100192 (2022).
  • Pan W-T, Liu P-M, Ma D, Yang J-J. Advances in photobiomodulation for cognitive improvement by near-infrared derived multiple strategies. J Transl Med. 21(1), 135 (2023).
  • Lopez A, Brundage C. Wound Photobiomodulation Treatment Outcomes in Animal Models. J. Vet. Med. 2019, 6320515 (2019).